
    
      The study will evaluate the clinical performance of cruciate ligament retaining or cruciate
      ligament substituting implants through a series of primary TKAs. Patients will receive either
      the P.F.C.® Sigma™ Rotating Platform Cruciate Retaining Knee implant or the P.F.C.® Sigma™
      Rotating Platform Cruciate Substituting Knee implant and assignment will be randomized.
    
  